Heart–lung transplant

Great News for Nevada Police Officers and Firefighters as GGRM Law Firm Wins Historic Ruling

Retrieved on: 
Wednesday, May 3, 2023

LAS VEGAS, May 3, 2023 /PRNewswire/ -- GGRM Law Firm announced today that the Nevada Supreme Court has issued an en banc 6 to 0 ruling in favor of all Police Officers and Firefighters in the state.

Key Points: 
  • LAS VEGAS, May 3, 2023 /PRNewswire/ -- GGRM Law Firm announced today that the Nevada Supreme Court has issued an en banc 6 to 0 ruling in favor of all Police Officers and Firefighters in the state.
  • Senior Partner, Lisa Anderson, served as lead counsel for Claimant, LVMPD Officer Robert Holland, in this historic victory.
  • The ruling clarifies that the burden of proof to deny Heart/Lung benefits based on "predisposing conditions" rests with the department, not the claimant.
  • "We are thrilled to have won this historic ruling for Nevada's Police Officers and Firefighters," said Lisa Anderson, Senior Partner at GGRM Law Firm.

OneLegacy Leads Nation in Lung Transplants in 2020

Retrieved on: 
Wednesday, January 27, 2021

OneLegacy announced today that in the year just concluded it was responsible for the most lung transplants in the nation, and the most lives saved, among the national network of 58 organ procurement organizations serving all of America.

Key Points: 
  • OneLegacy announced today that in the year just concluded it was responsible for the most lung transplants in the nation, and the most lives saved, among the national network of 58 organ procurement organizations serving all of America.
  • Of particular note, in 2020 OneLegacy provided 64% of all the lung transplants done at Ronald Reagan UCLA Medical Center.
  • The 121 lungs transplanted at UCLA was a 30% increase over the prior year and the third most lung transplants anywhere in the nation.
  • The announcement of OneLegacys lung transplant performance is part of its record-setting 2020, which saw the organization lead the nation in deceased donor organ transplants.

JHLT releases first reports of heart transplant recipients infected with COVID-19

Retrieved on: 
Wednesday, March 18, 2020

ADDISON, Texas, March 18, 2020 (GLOBE NEWSWIRE) -- The Journal of Heart and Lung Transplantationreleased the first report examining the impact of COVID-19 on two heart transplant recipients who contracted the virus in their native China.

Key Points: 
  • ADDISON, Texas, March 18, 2020 (GLOBE NEWSWIRE) -- The Journal of Heart and Lung Transplantationreleased the first report examining the impact of COVID-19 on two heart transplant recipients who contracted the virus in their native China.
  • The two patients presented with varied levels of severity -- one mild, the other more severe and requiring prolonged hospitalization.
  • Well need to study a broader pool of patients, but its possible that, among heart transplant recipients, the anti-inflammatory effects of immunosuppression actually lessen the expression of COVID-19 into its severe stages, said Dr. Mehra.
  • It is unknown if heart transplant recipients have differential expression of pulmonary ACE-2, since a lower expression may result in less severe illness.

Tampa General Hospital is First in Florida to Use New Organ Transplant System for Three Different Organs

Retrieved on: 
Monday, January 6, 2020

The first lung transplant in Florida using this system was performed at Tampa General Hospital on October 22, 2019.

Key Points: 
  • The first lung transplant in Florida using this system was performed at Tampa General Hospital on October 22, 2019.
  • Tampa General Hospital is the only hospital in Florida and among a handful in the United States to be using or formally studying the process for all three of these organs using the Organ Care System technology.
  • And Tampa General Hospital performed the first such lung transplant in Florida on Oct. 22.
  • As one of the largest hospitals in Florida, Tampa General Hospital is first in the state to open a command center in partnership with GE Healthcare.

New Research Finds Signal of Decreased Early Post Transplant Survival in the New Heart Transplant System

Retrieved on: 
Wednesday, November 20, 2019

Minneapolis, MN, Nov. 20, 2019 (GLOBE NEWSWIRE) -- In an analysis of the new heart organ allocation system for transplant patients in the U.S., researchers have identified a signal of a decrease in heart transplant survival rates.

Key Points: 
  • Minneapolis, MN, Nov. 20, 2019 (GLOBE NEWSWIRE) -- In an analysis of the new heart organ allocation system for transplant patients in the U.S., researchers have identified a signal of a decrease in heart transplant survival rates.
  • The study, An Early Investigation of Outcomes with the 2018 Donor Heart Allocation System in the United States, is published as a rapid communication in the Journal of Heart and Lung Transplantation.
  • For the first time in over a decade, modifications were made to the U.S. donor heart allocation system in October of 2018, aimed at better distinguishing the most medically urgent heart transplant candidates.
  • The new system was envisioned to allow more equitable organ allocation while providing an overall benefit to patients awaiting heart transplantation.

Paragonix SherpaPak™ Cardiac Transport System to be Demonstrated at the International Society for Heart and Lung Transplantation 2019 Annual Meeting

Retrieved on: 
Thursday, March 28, 2019

Paragonix executives will be at booth #409/411 providing hands-on demonstrations of its Paragonix SherpaPak Cardiac Transport System (CTS) , the industrys only FDA cleared and CE marked system for donor organ heart transport and storage.

Key Points: 
  • Paragonix executives will be at booth #409/411 providing hands-on demonstrations of its Paragonix SherpaPak Cardiac Transport System (CTS) , the industrys only FDA cleared and CE marked system for donor organ heart transport and storage.
  • The Paragonix SherpaPak CTS has been used by heart transplant centers in both the United States and Europe.
  • The International Society for Heart and Lung Transplantation (ISHLT), established in 1981, is a professional organization committed to research and education in heart and lung disease and transplantation.
  • Paragonix SherpaPak CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation.